News
2h
Investor's Business Daily on MSNMcDonald's Stock Bitten By Big Downgrade Over Weight-Loss DrugsMcDonald's stock was cut from buy to sell over a potential double-digit loss in sales due to weight-loss drugs.
Novo Nordisk (NYSE:NVO) rose to its highest level in over two months Monday after a media report said hedge fund Parvus Asset ...
Detailed price information for Eli Lilly and Company (LLY-N) from The Globe and Mail including charting and trades.
UBS is holding firm on its Buy rating and $1,050 price target for Eli Lilly, driven by faith in the upcoming SURPASS-CVOT ...
These companies own 97% of the weight loss drug market -- which could grow tenfold over the next decade -- and are developing ...
Aleniglipron’s tolerability could be a differentiator for Structure Therapeutics, but its efficacy lags competitors. Read why ...
Pfizer's stock experienced a 2.66% increase on June 9, 2025, closing at $23.97, marking its second consecutive day of gains.
Investing.com -- Parvus Asset Management, a London-based activist hedge fund, is acquiring a stake in Danish pharmaceutical company Novo Nordisk (NYSE: NVO ), according to The Financial Times. The ...
Companies are always in the race for the top spot, and the only way to achieve it is by reaching a high market valuation. The ...
We came across a bullish thesis on Eli Lilly and Company (LLY) on Business Model Mastery’s Substack. In this article, we will ...
1d
Zacks Investment Research on MSNEli Lilly and Company (LLY) Is a Trending Stock: Facts to Know Before Betting on ItEli Lilly (LLY) is one of the stocks most watched by Zacks.com visitors lately. So, it might be a good idea to review some of ...
Chugai plans to pair its muscle-preserving drug with Eli Lilly's orforglipron, addressing muscle loss in obesity care as the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results